Difficulty: Medium
Average Score: 84%
Practice
A nurse has administered Methergine (methylergonovine) 0.2 mg po to a grand multipara who delivered vaginally 30 minutes earlier. Which of the following outcomes indicates that the medication is effective?
Correct answer
C
Rationale
The correct answer is C) Fundus firm at umbilicus.
Postpartum hemorrhage is a significant concern after childbirth, especially in grand multiparas. Methergine is a medication commonly used to prevent or treat postpartum hemorrhage by promoting uterine contraction, which helps to control bleeding. A firm fundus at the umbilicus indicates that the medication is effective as it signifies proper uterine contraction, which is essential for preventing excessive bleeding.
Option A, blood pressure 120/80, and option B, pulse rate 80 bpm and regular, are not direct indicators of the effectiveness of Methergine in preventing postpartum hemorrhage. While changes in blood pressure and pulse rate can occur as side effects of the medication, they do not directly confirm its effectiveness in controlling bleeding.
Option D, an increase in prothrombin time, is incorrect because Methergine does not affect clotting factors or coagulation parameters like prothrombin time. Monitoring clotting factors would be more relevant if the patient was on anticoagulant therapy.
This question is important in the context of postpartum care as it highlights the need for nurses to understand the actions of medications commonly used in the management of postpartum complications, such as hemorrhage. Recognizing the appropriate assessment findings that indicate the effectiveness of medications like Methergine is crucial for providing safe and effective care to postpartum patients.
Postpartum hemorrhage is a significant concern after childbirth, especially in grand multiparas. Methergine is a medication commonly used to prevent or treat postpartum hemorrhage by promoting uterine contraction, which helps to control bleeding. A firm fundus at the umbilicus indicates that the medication is effective as it signifies proper uterine contraction, which is essential for preventing excessive bleeding.
Option A, blood pressure 120/80, and option B, pulse rate 80 bpm and regular, are not direct indicators of the effectiveness of Methergine in preventing postpartum hemorrhage. While changes in blood pressure and pulse rate can occur as side effects of the medication, they do not directly confirm its effectiveness in controlling bleeding.
Option D, an increase in prothrombin time, is incorrect because Methergine does not affect clotting factors or coagulation parameters like prothrombin time. Monitoring clotting factors would be more relevant if the patient was on anticoagulant therapy.
This question is important in the context of postpartum care as it highlights the need for nurses to understand the actions of medications commonly used in the management of postpartum complications, such as hemorrhage. Recognizing the appropriate assessment findings that indicate the effectiveness of medications like Methergine is crucial for providing safe and effective care to postpartum patients.